LUNG CYST BENIGN

This adverse event was reported 11 times

These drugs are most commonly taken by patients reporting LUNG CYST BENIGN:

# Drug Count
0 TACROLIMUS 2
1 TACROLIMUS EXTENDED-RELEASE CAPSULES 2
2 TACROLIMUS OINTMENT 0.1% 2
3 ADALIMUMAB 1
4 ATENOLOL 1
5 AZATHIOPRINE 1
6 BUSULFAN 1
7 CARBOPLATIN 1
8 DARBEPOETIN ALFA 1
9 DOCUSATE SODIUM 1
See all common drugs associated with LUNG CYST BENIGN

LUNG CYST BENIGN is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TOLMETIN SODIUM 1 0.0059
1 TOREMIFENE CITRATE 1 0.0023
2 BUSULFAN 1 0.0001
3 MELPHALAN HYDROCHLORIDE 1 0.0000
4 MYCOPHENOLIC ACID 1 0.0000
5 NITROGLYCERIN 1 0.0000
6 DARBEPOETIN ALFA 1 0.0000
7 DOCUSATE SODIUM 1 0.0000
8 ESTROGENS, CONJUGATED 1 0.0000
9 TACROLIMUS OINTMENT 0.1% 2 0.0000
See all drugs enriched for association with LUNG CYST BENIGN

LUNG CYST BENIGN is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Erythropoiesis-stimulating Agent [EPC] 1 0.0000
1 HER2/neu Receptor Antagonist [EPC] 1 0.0000
2 Nitrate Vasodilator [EPC] 1 0.0000
3 Purine Antimetabolite [EPC] 1 0.0000
4 Parathyroid Hormone Analog [EPC] 1 0.0000
5 Estrogen [EPC] 1 0.0000
6 Thiazide Diuretic [EPC] 1 0.0000
7 Alkylating Drug [EPC] 1 0.0000
8 Platinum-based Drug [EPC] 1 0.0000
9 beta-Adrenergic Blocker [EPC] 1 0.0000
See all drug classes enriched for association with LUNG CYST BENIGN